Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes

American Journal of Pathology

Volumn 163, Issue 1, 2003, Pages 37-45

  Chen, Chuan Mu ^c   Chen, Hsiao Ling ^a   Hsiau, Timothy H C ^a   Hsiau, Andrew H A ^a   Shi, Huidong ^a   Brock, Graham J R ^b   Wei, Susan H ^a   Caldwell, Charles W ^a   Yan, Pearlly S ^a   Huang, Tim Hui Ming ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c University of Missouri ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER CELL CULTURE; CPG ISLAND; DNA DETERMINATION; DNA FLANKING REGION; DNA METHYLATION; DNA MICROARRAY; GENE LOCUS; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

EID: 0037970043     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63628-0     Document Type: Article

References (24)

1. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 1986, 321:209-213
2. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP: Alterations in DNA methylation: a fundamental aspect of neoplasia. Advances in Cancer Research, vol 72. Edited by GF Vande Woude and G Klein. San Diego, Academic Press, 1997, pp 141-196
3. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Genet 2002, 3:415-428
4. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 2001, 61:3225-3229
5. Huang TH-M, Perry MR, Laux DE: Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 1999, 8:459-470
6. Yan P, Perry M, Laux D, Asare A, Caldwell C, Huang TH-M: CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin Cancer Res 2000, 6: 1432-1438
7. Yan PS, Chen C-M, Shi H, Rahmatpanah F, Wei SH, Caldwell CW, Huang TH-M: Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res 2001, 61:8375-8380
8. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847
9. Beahrs OH: American Joint Committee on Cancer: Manual for Staging of Cancer. Philadelphia, J. B. Lippincott Co., 1992, pp 149-154
10. Yan PS, Rodriguez FJ, Laux DE, Perry MR, Standiford SB, Huang TH-M: Hypermethylation of ribosomal RNA genes in human breast carcinoma. Br J Cancer 2000, 82:514-517
11. Shiraishi M, Lerman L, Seyika T: Preferential isolation of DNA fragments associated with CpG islands. Proc Natl Acad Sci USA 1995, 92:4229-4233
12. Brock GJR, Huang TH-M, Chen C-M, Johnson KJ: A novel technique for the identification of CpG islands exhibiting altered methylation patterns (ICEAMP). Nucleic Acids Res 2001, 29:e231
13. Xiang YY, Ladeda V, Filmus J: Glypican-3 expression is silenced in human breast cancer. Oncogene 2001, 20:7408-7412
14. Dammann R, Yang G, Pfeifer GP: Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 2001, 61:3105-3109
15. Lehmann U, Celikkaya G, Hasemeier B, Langer F, Kreipe H: Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. Cancer Res 2002, 62:6634-6638
16. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S: Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation, Cancer Res 2001, 61:921-925
17. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S: Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000, 405:974-978
18. Guo Y, Pakneshan P, Gladu J, Slack A, Szyf M, Rabbani SA: Regulation of DNA methylation in human breast cancer: effect on the urokinase-type plasminogen activator gene production and tumor invasion, J Biol Chem 2002, 277:41571-41579
19. Shworak NW, Liu J, Petros LM, Zhang L, Kobayashi M, Copeland NG, Jenkins NA, Rosenberg RD: Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase: Isolation, characterization, and expression of human cDNAs and identification of distinct genomic loci. J Biol Chem 1999, 274:5170-5184
20. Yang X, Yan L, Davidson NE: DNA methylation in breast cancer. Endocrinol Relat Cancer 2001, 8:115-127
21. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, Goggins M: Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000, 60:1835-1839
22. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999, 96:8681-8686
23. Strathdee G, Appleton K, Illand M, Millan DWM, Sargent J, Paul J, Brown R: Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol 2001, 158:1121-1127
24. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000, 24:132-138